IP Verse

Medicinal Composition For Treating Cancer

Patent No. EP3431105 (titled "Medicinal Composition For Treating Cancer") was filed by Osaka University on Mar 28, 2018. The application was issued on Jan 1, 2020.

Patent Summary

Antitumor drug that inhibits immunosuppression mediated by Treg cells or the like. The drug includes an antibody against CCR8 which inhibits immunosuppression mediated by Treg cells or the like and to provide a pharmaceutical composition for cancer treatment.

Patent Family

Patent Family

Patent Oppositions (5)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
GEVERS & ORESOct 1, 2020GEVERS PATENTS
J A KEMPOct 1, 2020J A KEMP
SCHIWECK WEINZIERL KOCH PATENTANWALTE PARTNERSCHAFT MBBOct 1, 2020SCHIWECK WEINZIERL KOCH PATENTANWALTE PARTNERSCHAFT MBB
GLAXOSMITHKLINESep 30, 2020KIM
KONIG SZYNKA TILMANN VON RENESSESep 16, 2020KONIG SZYNKA TILMANN VON RENESSE PATENTANWALTE PARTNERSCHAFT MBB DUSSELDORF

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP3431105

OSAKA UNIVERSITY
Application Number
EP18775737A
Filing Date
Mar 28, 2018
Status
Revoked
Jul 4, 2025
Publication Date
Jan 1, 2020
External Links
Slate, Register , Google Patents